Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polysynaptic pathways in the spinal cord represent complex neural circuits consisting of one or more interneurons interposed between a sensory (afferent) neuron and a motor (efferent) neuron. Unlike monosynaptic reflexes, these pathways allow for significant integration, divergence, and convergence of signals, facilitating sophisticated motor responses such as the flexor withdrawal reflex and the modulation of muscle tone (PubMed, 2021). These circuits are essential for coordinated movement but can become pathological following central nervous system injury, leading to clinical manifestations like spasticity and hyperreflexia (StatPearls, 2023). Pharmacological intervention typically focuses on depressing the excitability of these polysynaptic arcs to alleviate muscle spasms and pain. Central muscle relaxants, such as baclofen and tizanidine, exert their effects by targeting specific receptors (GABA-B and Alpha-2 adrenergic, respectively) located on the interneurons within these pathways (NIH, 2022). While not a single molecular target, the modulation of these pathways remains a cornerstone in the management of neurological disorders involving motor dysfunction.
Drugs modulate these pathways by acting as agonists at inhibitory receptors (GABA-B or Alpha-2 adrenergic) or by increasing GABAergic inhibition, thereby reducing the excitability of spinal interneurons and alpha motor neurons (StatPearls, 2023; NIH, 2022).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polysynaptic pathways in the spinal cord (PSPS).